title: Dabigatran product familiarisation programmes: who benefits, who shouldn't get it?
authors.forename: H
authors.initials: H
authors.lastname: Curley
authors.forename: C
authors.initials: C
authors.lastname: Denaro
mesh_terms: D000369:Aged, 80 and over; D000740:Anemia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D001562:Benzimidazoles / Q000009:adverse effects* / Q000097:blood; D000069604:Dabigatran; D005260:Female; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000379:methods* / Q000639:trends; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran